Human Collagen
Engineered for Structural Fidelity

Developed through a proprietary in-vitro tissue-regeneration platform, RégénéColla™ is a human-cell-derived collagen matrix characterised from chain profile to triple-helix conformation and fibrillar organisation. A rigorous approach to structural biomaterials.

Intact Triple-Helix Profile

The triple helix is a defining feature of collagen. RégénéColla™ is assessed for a right-handed triple-helical profile using structural methods that should be interpreted together with the approved analytical report.

Biological Compatibility

A human-cell-derived source avoids the cross-species origin of bovine, porcine and marine collagen. Biological compatibility still depends on the final product, route of use and product-specific evaluation.

Lot-to-Lot Consistency

Controlled in-vitro production and defined downstream processing are designed to support reproducible material attributes. Lot consistency is evaluated against the approved specification.

Defined Type I Chain Profile

The reported SDS-PAGE profile shows distinct α1 and α2 bands at approximately 116 kDa and 97 kDa, supporting the stated Type I collagen chain profile.

Controlled Purification

Downstream purification is designed to control cellular residues, endotoxin and non-collagenous process impurities. Release limits should be read from the specification for the relevant material grade.

Cytocompatibility Assessed

Cytocompatibility is assessed within the quality and preclinical programme for the relevant product. Test method, sample identity and acceptance criteria are necessary for interpreting the result.

RégénéColla™ is produced through tissue engineering and controlled in-vitro human-cell culture, followed by downstream purification and structural characterisation. This page explains how the material is made and assessed; performance and clinical claims remain specific to the final product and approved use.